Your data or your life?

Your data or your life?

As governments around the world scramble to manage the coronavirus outbreak, the location data tracked by your mobile phone has become a highly sought-after commodity. Authorities in China, Israel, Russia, the US, and even the uber-privacy-conscious European Union have either secured access to mobile phone location data that they can use to identify people at risk of infection, or they are trying to get their hands on it.

But is this really a good idea? Here are the arguments for and against:

This is an emergency, track everyone: If there were ever a time to set concerns about privacy aside, this is it. Giving public health authorities access to everyone's location data gives them a better chance of tracking down people who have been in contact with confirmed cases – and helps ensure that those who are already sick stay in quarantine. Right now, governments need all the help they can get. Give them the data. Debates about the privacy implications can wait.


China is in this camp. So are other countries in Asia, like South Korea and Taiwan, that have had better success containing the epidemic – although it's still too early to say whether access to mobile phone location data was the deciding factor.

The risks to privacy are too great. Plus, there's no guarantee this will work: Anybody expecting governments and citizens to engage in level-headed debate about the potential trade-offs between public health and personal privacy during a raging crisis is probably smoking something. Governments will be looking to grab as much power as they can and history shows that they rarely give special powers back even after crises subside. Plus, all the data in the world isn't much use without a plan to put it to work. By the time governments figure it out, the pandemic may already be too widespread for digital tools like this to make a big difference.

Of course, politics is rarely so black and white. Europe, for example, is trying to carve out a middle way – it's asking mobile phone companies to share anonymized location data to help stem the spread of the virus in a way that still adheres to the bloc's tough data protection laws, while also issuing guidance to those member states who do want to pass emergency legislation that would allow for more detailed tracking.

Who's got it right? Is there another approach here that we are missing? Let us know your thoughts here.

As digital technology reshapes the workplace, a move toward skills-based training and employment will unlock opportunities for companies and job seekers alike. While automation and AI are already taking on many routine tasks, demand for people with technology skills is rising fast around the globe. Getting the right people into the right jobs within the right organizations is one of the biggest challenges facing the world of work. So how can it be overcome? To read some recent skills-related stories, visit Microsoft On the Issues.

In recent days, Northern Ireland has seen some of its worst street violence in over a decade. The anger has subsided a bit this week, but post-Brexit fears leave many uncertain about their future in a deeply divided land with a long history of political violence between Irish republicans and UK unionists.

More Show less

Iran has vowed to avenge Sunday's attack on its Natanz nuclear facility. Tehran blames Israel, which — as in the past — has neither confirmed nor denied it was responsible. And all this happens just days after indirect talks on US plans to rejoin the 2015 Iran nuclear deal resumed in Vienna. What the Iranians do now will determine the immediate future of those negotiations, a Biden administration priority.

More Show less

The end of "forever" in Afghanistan: The Biden administration says it'll withdraw all remaining US troops in Afghanistan by September 11, the 20th anniversary of the 9/11 attacks that prompted Washington to invade the country in the first place. It's unclear how the withdrawal will affect American plans to steer intra-Afghan peace talks in the right direction under the terms of a peace agreement reached by the Trump administration and the Taliban in May 2020. Trump promised to pull out next month as long as the former al-Qaida hosts kept their end of the bargain by not launching deadly attacks (spoiler alert: they have not). Biden's move honors his campaign pledge to end a "forever war" that has claimed more than 2,300 American lives and cost the US Treasury almost $1 trillion since 2001. However, critics fear that a hasty departure could leave the Afghans helpless to prevent the Taliban from returning to power, rendering the entire mission not only expensive, but ultimately pointless.

More Show less

Ian Bremmer shares his perspective on global politics this week on World In 60: J&J vaccine woes, Blinken warns China, Fukushima water and a large rabbit.

How will the pause of Johnson & Johnson vaccine affect the overall pandemic fight in the United States?

Yeah. Right at it, right? Well, we heard that the FDA has suspended vaccines from J&J because of blood clots. They found six in seven million cases. It's kind of like the suspension of AstraZeneca in Europe. It's likely only going to last for a few days. It's a very small percentage of the total number of vaccines that are being jabbed right now into the arms of Americans. It's not going to really slow America's ability to get everyone vaccinated, but it is going to create more vaccine hesitancy. People at the margins will say, "Is this safe? They said it was fine. Now they're saying it's not okay." I understand why there's enormous caution on the part of the FDA, but I wish, wish, wish the communications had been a little softer around all of this. Also will be a problem in terms of export, as J&J is going to be a piece of that. And again, others around the world will say, "Well, if I don't get Moderna, if I don't get Pfizer, I'm not sure I want to take it at all." So all of this is negative news, though I would still say the United States this year is looking really, really good among major economies in dealing with pandemic.

More Show less

750 million: While struggling with one of the worst coronavirus outbreaks in the world right now, India has approved Russia's Sputnik V COVID vaccine. Moscow has a deal in place to produce 750 million doses of the shot in India.

More Show less

In recent weeks, both Pfizer and Moderna have announced early phases of vaccine trials in children, and Johnson & Johnson also plans to start soon. If you know a kid who wants to learn about vaccines, how they work, why we need them, this story is just what the doctor ordered.

Watch the episode: Vaccine nationalism could prolong the pandemic

Ian Bremmer's Quick Take:

Hi everybody. Ian Bremmer here. Welcome to your week and I've got your Quick Take and thought I would talk a little bit about where we are with Iran. One of the Biden administration's promises upon election was to get the Americans back into the JCPOA, the Iranian nuclear deal. As of last week, negotiations are formally restarted, and pretty quickly, in Vienna, they're not direct. The Americans and Iranians are both there, but they're being intermediated by the Europeans because they're not yet ready to show that they can talk directly to each other. That's Iran being cautious in the run-up to their presidential election coming this summer. But the movement is there. So far the talk has largely been about sequencing the Iranian government, saying that all of the sanctions need to be removed before they're willing to go back into the deal, because the Americans after all, unilaterally withdrew from a deal that the Iranians were indeed adhering to, and the inspections did confirm that.

More Show less

Subscribe to GZERO Media's newsletter, Signal

The GZERO World Podcast with Ian Bremmer. Listen now.

GZEROMEDIA

Subscribe to GZERO Media's newsletter: Signal

A children’s book on vaccination

GZERO World Clips